Phase I Study of Thrice Weekly Hu1D10*in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Acute Leukemia.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Apolizumab (Primary)
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 05 Dec 2012 Actual end date Apr 2006 added as reported by ClinicalTrials.gov.
- 25 Sep 2005 New trial record.